Potential Mechanisms Underlying the Increased Excitability of the Bladder Afferent Pathways in Interstitial Cystitis/Bladder Pain Syndrome

키워드

참고문헌 (69)

1. Konkle KS, "Comparison of an interstitial cystitis", bladder pain syndrome clinical cohort with symptomatic community women from the RAND interstitial cystitis epidemiology study, 2012, pp.187, 508~512
2. Choe JH, "Prevalence of painful bladder syndrome", interstitial cystitis-like symptoms in women: a population-based study in Korea, 2011, pp.29, 103~108
3. Hanno PM, "AUA guideline for the diagnosis and treatment of interstitial cystitis", bladder pain syndrome, 2011, pp.185, 2162~2170
4. Yoshimura N, "Bladder afferent hyperexcitability in bladder pain syndrome", interstitial cystitis, 2014, pp.21, 18~25
5. Chancellor MB, "Treatment of interstitial cystitis", Urology, 63, pp.85~92 (2004)[DOI]
6. Grover S, "Role of inflammation in bladder function and interstitial cystitis", Ther Adv Urol, 3, pp.19~33 (2011)[DOI]
7. Birder LA, "Role of neurogenic inflammation in local communication in the visceral mucosa", Semin Immunopathol, 40, pp.261~279 (2018)[DOI]
8. Schrepf A, "Inflammation and inflammatory control in interstitial cystitis", bladder pain syndrome: associations with painful symptoms, 2014, pp.155, 1755~1761
9. Birder L, "Urothelial signaling", Physiol Rev, 93, pp.653~680 (2013)[DOI]
10. Yoshimura N, "Therapeutic receptor targets for lower urinary tract dysfunction", Naunyn Schmiedebergs Arch Pharmacol, 377, pp.437~448 (2008)[DOI]
11. Fowler CJ, "The neural control of micturition", Nat Rev Neurosci, 9, pp.453~466 (2008)[DOI]
12. de Groat WC, "Neural control of the lower urinary tract", Compr Physiol, 5, pp.327~396 (2015)
13. de Groat WC, "Anatomy and physiology of the lower urinary tract", Handb Clin Neurol, 130, pp.61~108 (2015)
14. Habler HJ, "Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat", J Physiol, 425, pp.545~562 (1990)[DOI]
15. Fall M, "A bladder-to-bladder cooling reflex in the cat", J Physiol, 427, pp.281~300 (1990)[DOI]
16. Yoshimura N, "Targeting afferent hyperexcitability for therapy of the painful bladder syndrome", Urology, 59, pp.61~67 (2002)[DOI]
17. Geppetti P, "The concept of neurogenic inflammation", BJU Int, 101(Suppl 3), pp.2~6 (2008)
18. Rosa AC, "The role of histamine in neurogenic inflammation", Br J Pharmacol, 170, pp.38~45 (2013)[DOI]
19. Sculptoreanu A, "Abnormal excitability in capsaicin-responsive DRG neurons from cats with feline interstitial cystitis", Exp Neurol, 193, pp.437~443 (2005)[DOI]
20. Roppolo JR, "Bladder Adelta afferent nerve activity in normal cats and cats with feline interstitial cystitis", J Urol, 173, pp.1011~1015 (2005)[DOI]
21. Gao Y, "The role of C-fibers in the development of chronic psychological stress induced enhanced bladder sensations and nociceptive responses: a multidisciplinary approach to the study of urologic chronic pelvic pain syndrome (MAPP) research network study", Neurourol Urodyn, 37, pp.673~680 (2018)[DOI]
22. Vizzard MA, "Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation", J Comp Neurol, 370, pp.191~202 (1996)[DOI]
23. Vizzard MA, "Increased expression of growthassociated protein (GAP-43) in lower urinary tract pathways following cyclophosphamide (CYP)-induced cystitis", Brain Res, 844, pp.174~187 (1999)[DOI]
24. Vizzard MA, "Up-regulation of pituitary adenylate cyclaseactivating polypeptide in urinary bladder pathways after chronic cystitis", J Comp Neurol, 420, pp.335~348 (2000)[DOI]
25. Vizzard MA, "Alterations in neuropeptide expression in lumbosacral bladder pathways following chronic cystitis", J Chem Neuroanat, 21, pp.125~138 (2001)[DOI]
26. Dattilio A, "Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers", J Urol, 173, pp.635~639 (2005)[DOI]
27. Pang X, "Increased number of substance P positive nerve fibres in interstitial cystitis", Br J Urol, 75, pp.744~750 (1995)[DOI]
28. Marchand JE, "Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis", Br J Urol, 81, pp.224~228 (1998)[DOI]
29. Theoharides TC, "Mast cell involvement in interstitial cystitis: a review of human and experimental evidence", Urology, 57, pp.47~55 (2001)[DOI]
30. Theoharides TC, "Interstitial cystitis: a neuroimmunoendocrine disorder", Ann N Y Acad Sci, 840, pp.619~634 (1998)[DOI]
31. Christmas TJ, "Nerve fibre proliferation in interstitial cystitis", Virchows Arch A Pathol Anat Histopathol, 416, pp.447~451 (1990)[DOI]
32. Brady CM, "Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment", BJU Int, 93, pp.770~776 (2004)[DOI]
33. Ochodnicky P, "Neurotrophins as regulators of urinary bladder function", Nat Rev Urol, 9, pp.628~637 (2012)[DOI]
34. Okragly AJ, "Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients", J Urol, 161, pp.438~441 (1999)[DOI]
35. Lowe EM, "Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis", Br J Urol, 79, pp.572~577 (1997)[DOI]
36. Bjorling DE, "Intravesical Escherichia coli lipopolysaccharide stimulates an increase in bladder nerve growth factor", BJU Int, 87, pp.697~702 (2001)
37. Dmitrieva N, "The role of nerve growth factor in a model of visceral inflammation", Neuroscience, 78, pp.449~459 (1997)[DOI]
38. Zvara P, "Exogenous overexpression of nerve growth factor in the urinary bladder produces bladder overactivity and altered micturition circuitry in the lumbosacral spinal cord", BMC Physiol, 7, pp.9~ (2007)[DOI]
39. Qiao LY, "Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways", J Comp Neurol, 454, pp.200~211 (2002)[DOI]
40. Qiao L, "Up-regulation of tyrosine kinase (Trka, Trkb) receptor expression and phosphorylation in lumbosacral dorsal root ganglia after chronic spinal cord (T8-T10) injury", J Comp Neurol, 449, pp.217~230 (2002)[DOI]
41. Pinto R, "Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome", interstitial cystitis, 2010, pp.58, 360~365
42. Pinto R, "Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis", Neuroscience, 166, pp.907~916 (2010)[DOI]
43. Abdiche YN, "Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors", Protein Sci, 17, pp.1326~1335 (2008)[DOI]
44. Nickel JC, "Tanezumab reduces pain in women with interstitial cystitis", bladder pain syndrome and patients with nonurological associated somatic syndromes, 2016, pp.195, 942~948
45. Evans RJ, "Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis", J Urol, 185, pp.1716~1721 (2011)[DOI]
46. Dodds KN, "Glial contributions to visceral pain: implications for disease etiology and the female predominance of persistent pain", Transl Psychiatry, 6, pp.e888~ (2016)[DOI]
47. Baron R, "Peripheral input and its importance for central sensitization", Ann Neurol, 74, pp.630~636 (2013)[DOI]
48. Reynolds WS, "Does central sensitization help explain idiopathic overactive bladder?", Nat Rev Urol, 13, pp.481~491 (2016)[DOI]
49. Grace PM, "Pathological pain and the neuroimmune interface", Nat Rev Immunol, 14, pp.217~231 (2014)[DOI]
50. Milligan ED, "Pathological and protective roles of glia in chronic pain", Nat Rev Neurosci, 10, pp.23~36 (2009)[DOI]
51. Mohsen Tabasi, "Phenotypic Assays to Determine Virulence Factors of Uropathogenic Escherichia coli (UPEC) Isolates and their Correlation with Antibiotic Resistance Pattern", Osong Public Health and Research Perspectives, 6(4), pp.261~268 (2015), 질병관리청
52. Reygaert WC, "Innate immune response to urinary tract infections involving Escherichia coli", J Clin Cell Immunol, 5, pp.280~ (2014)
53. Abraham SN, "Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae", Nature, 336, pp.682~684 (1988)[DOI]
54. Zhou G, "Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding", J Cell Sci, 114, pp.4095~4103 (2001)
55. Agier J, "An overview of mast cell pattern recognition receptors", Inflamm Res (2018)[DOI]
56. Akira S, "Pathogen recognition and innate immunity", Cell, 124, pp.783~801 (2006)[DOI]
57. Medzhitov R, "A human homologue of the drosophila toll protein signals activation of adaptive immunity", Nature, 388, pp.394~397 (1997)[DOI]
58. Takeuchi O, "Pattern recognition receptors and inflammation", Cell, 140, pp.805~820 (2010)[DOI]
59. Behzadi E, "The role of toll-like receptors (TLRs) in urinary tract infections (UTIs)", Cent European J Urol, 69, pp.404~410 (2016)
60. Song J, "A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells", PLoS Pathog, 3, pp.e60~ (2007)[DOI]
61. Hutchinson MR, "Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)", Eur J Neurosci, 28, pp.20~29 (2008)[DOI]
62. Schrepf A, "Toll-like receptor 4 and comorbid pain in interstitial cystitis", bladder pain syndrome: a multidisciplinary approach to the study of chronic pelvic pain research network study, 2015, pp.49, 66~74
63. Kwok YH, "TLR 2 and 4 responsiveness from isolated peripheral blood mononuclear cells from rats and humans as potential chronic pain biomarkers", PLoS ONE, 8, pp.e77799~ (2013)[DOI]
64. Ellis A, "Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain", J Pain, 15, pp.407~421 (2014)[DOI]
65. Ichihara K, "Toll-like receptor 7 is overexpressed in the bladder of Hunner-type interstitial cystitis, and its activation in the mouse bladder can induce cystitis and bladder pain", Pain, 158, pp.1538~1545 (2017)[DOI]
66. Karl-Erik Andersson, "Current Pharmacologic Approaches in Painful Bladder Research: An Update", International Neurourology Journal, 21(4), pp.235~242 (2017), 대한배뇨장애요실금학회
67. Rosen JM, "Mechanisms of pain from urinary tract infection", Int J Urol, 21(Suppl 1), pp.26~32 (2014)[DOI]
68. Park BS, "The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex", Nature, 458, pp.1191~1195 (2009)[DOI]
69. Raetz CR, "Lipopolysaccharide endotoxins", Annu Rev Biochem, 71, pp.635~700 (2002)[DOI]

관련 논문AI추천